SHL to present at Pharmapack Symposium Taiwan 2017

News Page W740 X H540

SHL Group is proud to announce that it will participate in the Taiwan Pharmapack Symposium held in Taipei on March 30, 2017.

Olle Ljungquist, senior scientist at SHL Group, will give a talk on the “Requirements and Test Methods for Finished Prefilled Syringes.” The talk will focus on the use of syringes in needle based injection systems, compare the ISO 11040-8 and ISO 11040-4 standards, and look at the Hagen-Poiseuille equation to explore its impact on syringe and autoinjector testing.

SHL will also use this opportunity to showcase its extensive selection of drug delivery devices and technologies, including the Molly® family of devices, solutions for highly viscous drugs and other time-tested technologies in drug delivery.

Visit SHL at the Taipei Shangri-La’s Far Eastern Plaza Hotel to learn more about our devices, packaging solutions and innovative offers.

About Pharmapack Symposium Taiwan

The annual Pharmapack Symposium is a one-day workshop on primary packaging and drug delivery trends for injectables. Organization of the event is supported by Ompi, a worldwide producer of glass primary packaging for pharmaceutical industry. Building on the success of participation in previous years, SHL has once again become a proud sponsor of the workshop in Taiwan.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News